Evidence mapPaperPMID 41767280Full record

ReviewFrontiers in molecular neuroscience2026

Oxysterol signaling in the central nervous system: cellular mechanisms and implications for neurodegeneration.

Raphael P Ricci, Cheng Xiang Foo, Katharina Ronacher, Carlie L Cullen

Abstract readReview
In one paragraph

Review in Frontiers in molecular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raphael P RicciGlial Neurobiology, Cognition and Behaviour Research Laboratory, Faculty of Health, Medicine and Behavioural Sciences, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Cheng Xiang FooInfection, Immunity and Metabolism Laboratory, Faculty of Health, Medicine and Behavioural Sciences, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Katharina RonacherInfection, Immunity and Metabolism Laboratory, Faculty of Health, Medicine and Behavioural Sciences, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Carlie L CullenGlial Neurobiology, Cognition and Behaviour Research Laboratory, Faculty of Health, Medicine and Behavioural Sciences, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxysterols, oxidized derivatives of cholesterol, are key modulators of central nervous system (CNS) function. Acting as both signaling molecules and cytotoxic mediators, oxysterols can influence glial activity, neuroinflammation and myelination. Glial cells (astrocytes, oligodendrocytes, and microglia) maintain neuronal homeostasis, support synaptic plasticity and mediate CNS repair. Dysregulated glial function contributes to chronic neuroinflammation, a hallmark of neurodegenerative and neuropsychiatric disorders such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. In this review article, we discuss the roles of oxysterols in the CNS with a particular focus on their impact on glial cells, neuroinflammation, myelination and neural circuit function. Therapeutically targeting oxysterol metabolism may mitigate oxidative stress, limit apoptosis, enhance glial health and influence myelin repair. Elucidating oxysterol signaling in glia and neurons provides critical insight into neural circuit regulation and identifies promising strategies for treating demyelinating, neurodegenerative and neuropsychiatric disorders.

Indexed as

central nervous systemglianeurodegenerationneuroinflammationoxysterols

Identifiers

PMID41767280
PMCPMC12936014

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.